Silk fibroin-based nanoparticles for drug delivery

International Journal of Molecular Sciences
Zheng ZhaoMao-Bin Xie

Abstract

Silk fibroin (SF) is a protein-based biomacromolecule with excellent biocompatibility, biodegradability and low immunogenicity. The development of SF-based nanoparticles for drug delivery have received considerable attention due to high binding capacity for various drugs, controlled drug release properties and mild preparation conditions. By adjusting the particle size, the chemical structure and properties, the modified or recombinant SF-based nanoparticles can be designed to improve the therapeutic efficiency of drugs encapsulated into these nanoparticles. Therefore, they can be used to deliver small molecule drugs (e.g., anti-cancer drugs), protein and growth factor drugs, gene drugs, etc. This paper reviews recent progress on SF-based nanoparticles, including chemical structure, properties, and preparation methods. In addition, the applications of SF-based nanoparticles as carriers for therapeutic drugs are also reviewed.

References

Dec 1, 1976·Journal of Pharmaceutical Sciences·G Birrenbach, P P Speiser
Feb 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E R EdelmanM J Karnovsky
Jul 11, 2000·Pharmaceutical Research·J E BabenseeA G Mikos
Oct 29, 2003·Current Opinion in Biotechnology·Tanyarut Boontheekul, David J Mooney
Dec 9, 2003·Journal of Molecular Biology·Elisabetta BiniDavid L Kaplan
May 11, 2004·Biomacromolecules·Frantisek Sehnal, Michal Zurovec
Nov 24, 2004·Current Biology : CB·Daniel HuemmerichShmulik Ittah
Dec 29, 2004·Biomaterials·Rebecca L HoranGregory H Altman
Jul 25, 2006·Expert Opinion on Pharmacotherapy·Maurie Markman
Jan 27, 2007·Advances in Colloid and Interface Science·Julian EastoeLaura Hudson
Feb 13, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Catarina Pinto ReisFrancisco Veiga
May 15, 2007·International Journal of Pharmaceutics·Sangeeta K CheemaAnshu B Mathur
Aug 28, 2007·International Journal of Nanomedicine·Andrea S GobinAnshu B Mathur
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwangjae ChoDong M Shin
Apr 12, 2008·Journal of Colloid and Interface Science·Yunqing KangXiming Pu
Aug 5, 2008·Molecular Pharmaceutics·Frank AlexisOmid C Farokhzad
Dec 17, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiaoqin WangDavid L Kaplan
Dec 17, 2008·Journal of the American Chemical Society·Jih Ru HwuDar-Bin Shieh
Jun 12, 2009·International Journal of Nanomedicine·Vishal GuptaAnshu B Mathur
Jan 1, 2007·Progress in Polymer Science·Charu Vepari, David L Kaplan
Jul 7, 2009·Biomaterials·Keiji NumataDavid L Kaplan
Sep 29, 2009·Colloids and Surfaces. B, Biointerfaces·Avnesh KumariSubhash C Yadav
Dec 1, 2009·Biomaterials·Xiaoqin WangDavid L Kaplan
Jan 12, 2010·International Journal of Pharmaceutics·Joydip KunduS C Kundu
Mar 11, 2010·Handbook of Experimental Pharmacology·Frank AlexisOmid C Farokhzad
Mar 11, 2010·Advanced Materials·Gary G LeiskDavid L Kaplan
Mar 12, 2010·Biomaterials·Andreas S LammelThomas R Scheibel
Mar 20, 2010·Advanced Drug Delivery Reviews·Keiji Numata, David L Kaplan
May 12, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Keiji NumataDavid L Kaplan
Jun 4, 2010·Journal of the Royal Society, Interface·Sinan Keten, Markus J Buehler
Jul 29, 2010·Nanomedicine·Anshu B Mathur, Vishal Gupta
Jul 31, 2010·Science·Fiorenzo G Omenetto, David L Kaplan
Oct 15, 2010·Biomacromolecules·Keiji Numata, David L Kaplan
Nov 10, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Esther WenkLorenz Meinel
Jan 7, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Sreevidhya T KrishnajiDavid L Kaplan
Feb 25, 2011·Acta Biomaterialia·Qiang LuDavid L Kaplan
Jul 12, 2011·Bioconjugate Chemistry·Keiji NumataDavid L Kaplan
Aug 16, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ahmed O ElzoghbyNazik A Elgindy
Sep 17, 2011·International Journal of Pharmaceutics·Pujiang Shi, James C H Goh
Oct 25, 2011·Journal of Biomedical Materials Research. Part a·Mengjie ChenXin Chen
Nov 5, 2011·Macromolecular Bioscience·Keiji NumataDavid L Kaplan
Feb 4, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Susana Patricia EgusquiaguirreJosé Luis Pedraz

❮ Previous
Next ❯

Citations

Sep 30, 2015·Biomacromolecules·Thidarat WongpinyochitF Philipp Seib
Sep 29, 2015·Journal of Biomaterials Science. Polymer Edition·John G HardyChristine E Schmidt
Sep 7, 2016·International Journal of Molecular Sciences·Hyo Won KwakKi Hoon Lee
Jan 17, 2017·Bioconjugate Chemistry·Norifumi KawakamiKenji Miyamoto
Oct 20, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Supaporn SangkertWen Lin Chai
Feb 13, 2017·Carbohydrate Polymers·Mar Collado-GonzálezF Guillermo Díaz Baños
Dec 26, 2016·International Journal of Pharmaceutics·Antonio Abel Lozano-PérezJosé Luis Cénis
Jul 12, 2017·Langmuir : the ACS Journal of Surfaces and Colloids·Fernando Jativa, Xuehua Zhang
Feb 8, 2018·Macromolecular Bioscience·Xusheng XieXiaoqin Wang
Dec 1, 2017·Microbial Cell Factories·Qinglei DaiYuangang Liu
Sep 12, 2017·Journal of Biomedical Materials Research. Part a·Zahra EsmailiVahid Haddadi-Asl
Nov 21, 2018·Pharmaceutical Development and Technology·Pianpian YangChuanbin Wu
Jan 19, 2019·Current Pharmaceutical Design·Chahinez HouacineKamalinder K Singh
Jul 26, 2019·Dental Materials Journal·Yinying QuXiaodong Chen
Nov 9, 2019·Drug Delivery and Translational Research·Duy Toan PhamWaree Tiyaboonchai
Sep 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Felicia OnyeaborJeffrey Wang
Nov 7, 2019·Current Pharmaceutical Design·Mitra KoraniAmirhossein Sahebkar
Mar 12, 2020·Drug Delivery·Duy Toan Pham, Waree Tiyaboonchai
May 2, 2019·Scientific Reports·Salvador D Aznar-CervantesJosé L Cenis
Mar 12, 2020·Annual Review of Biomedical Engineering·Jung Woo LeemYoung L Kim
Jul 3, 2020·Pharmaceutics·Seyoung HongHee Ho Park
Sep 1, 2020·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Sharda GuptaArindam Bit
Mar 10, 2017·International Journal of Molecular Sciences·Yu QiKe-Qin Zhang
Dec 21, 2019·Advanced Pharmaceutical Bulletin·Hamid RahmaniYalda Shokoohinia
Aug 5, 2017·Materials·Dave JaoXiao Hu
Aug 1, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shuyu ZhanJeffrey Wang
Jan 13, 2018·Soft Matter·Barbara CrivelliMaria Luisa Torre
Dec 29, 2020·Macromolecular Bioscience·Yujia LiangRangam Rajkhowa
Nov 5, 2019·Advanced Drug Delivery Reviews·Mazaher GholipourmalekabadiSubhas C Kundu
Nov 27, 2020·Frontiers in Chemistry·Ya MaBo Xiao

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical modification
transfection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Nanomedicine
Jun Jie WangShu Ling Wang
BioMed Research International
Warangkana LohcharoenkalYon Rojanasakul
International Journal of Biological Macromolecules
M Prabaharan
Jundishapur Journal of Natural Pharmaceutical Products
Jebraeel MovaffaghHamideh Ghodrati Azadi
© 2022 Meta ULC. All rights reserved